| Jeffrey Joseph, MD | |
|
70 Kenyon Ave, Suite 103, Wakefield, RI 02879-4239 | |
| (401) 789-0661 | |
| Not Available |
| Full Name | Jeffrey Joseph |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 35 Years |
| Location | 70 Kenyon Ave, Wakefield, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689780165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD08267 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westerly Hospital | Westerly, RI | Hospital |
| South County Hospital Inc | Wakefield, RI | Hospital |
| Lawrence & Memorial Hospital | New london, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
For more than 40 years, patients under 65 years of age requiring heart valve replacement have had to choose between a mechanical valve that offers life-long durability but requires aggressive warfarin anticoagulation or a biological (cow or pig) valve that will wear out in 10-20 years but does not require anticoagulation.
Leading experts in the field of mental health are holding one of the largest conferences of its kind in Vancouver, November Sunday 29 - Tuesday December 1. The conference, titled 'Into the Light,' is being jointly organized by the Mental Health Commission of Canada, Vancouver Coastal Health and Simon Fraser University and will be looking at mental health issues across Canada.
Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.
Apathy offers an important early warning sign of dementia in individuals with cerebrovascular disease, but depression does not, new research led by the University of Cambridge suggests.
Valeant Pharmaceuticals International, Inc. announced today that Alexza Pharmaceuticals, Inc. has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Alexza's New Drug Application (NDA) for AZ-004 (Staccato® loxapine) submitted as Adusuve™ Staccato® (loxapine) inhalation aerosol, 5 mg and 10 mg.
› Verified 2 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20170518000594 |
News Archive
For more than 40 years, patients under 65 years of age requiring heart valve replacement have had to choose between a mechanical valve that offers life-long durability but requires aggressive warfarin anticoagulation or a biological (cow or pig) valve that will wear out in 10-20 years but does not require anticoagulation.
Leading experts in the field of mental health are holding one of the largest conferences of its kind in Vancouver, November Sunday 29 - Tuesday December 1. The conference, titled 'Into the Light,' is being jointly organized by the Mental Health Commission of Canada, Vancouver Coastal Health and Simon Fraser University and will be looking at mental health issues across Canada.
Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.
Apathy offers an important early warning sign of dementia in individuals with cerebrovascular disease, but depression does not, new research led by the University of Cambridge suggests.
Valeant Pharmaceuticals International, Inc. announced today that Alexza Pharmaceuticals, Inc. has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Alexza's New Drug Application (NDA) for AZ-004 (Staccato® loxapine) submitted as Adusuve™ Staccato® (loxapine) inhalation aerosol, 5 mg and 10 mg.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Joseph, MD Po Box 229, Wakefield, RI 02880-0229 Ph: (401) 788-3929 | Jeffrey Joseph, MD 70 Kenyon Ave, Suite 103, Wakefield, RI 02879-4239 Ph: (401) 789-0661 |
News Archive
For more than 40 years, patients under 65 years of age requiring heart valve replacement have had to choose between a mechanical valve that offers life-long durability but requires aggressive warfarin anticoagulation or a biological (cow or pig) valve that will wear out in 10-20 years but does not require anticoagulation.
Leading experts in the field of mental health are holding one of the largest conferences of its kind in Vancouver, November Sunday 29 - Tuesday December 1. The conference, titled 'Into the Light,' is being jointly organized by the Mental Health Commission of Canada, Vancouver Coastal Health and Simon Fraser University and will be looking at mental health issues across Canada.
Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.
Apathy offers an important early warning sign of dementia in individuals with cerebrovascular disease, but depression does not, new research led by the University of Cambridge suggests.
Valeant Pharmaceuticals International, Inc. announced today that Alexza Pharmaceuticals, Inc. has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Alexza's New Drug Application (NDA) for AZ-004 (Staccato® loxapine) submitted as Adusuve™ Staccato® (loxapine) inhalation aerosol, 5 mg and 10 mg.
› Verified 2 days ago
Dr. Steven Howard Schneider, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 70 Kenyon Ave, Suite 103, Wakefield, RI 02879 Phone: 401-789-0661 Fax: 401-788-9358 | |
Dr. Mary Christina Simpson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 155 Main St, Wakefield, RI 02879 Phone: 401-782-2400 | |
Robert T O'neill, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 70 Kenyon Ave Unit 215, Wakefield, RI 02879 Phone: 401-782-9900 | |
Joseph James O'neill, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 70 Kenyon Ave, Wakefield, RI 02879 Phone: 401-789-9210 Fax: 401-792-3699 | |
Andrew P Neuhauser, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 70 Kenyon Ave, Suite 103, Wakefield, RI 02879 Phone: 701-789-0661 Fax: 401-788-3958 | |
Megin L Dalton, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 70 Kenyon Ave, Suite 103, Wakefield, RI 02879 Phone: 401-789-0661 Fax: 401-788-3958 | |
Kathleen Anne Cassin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 70 Kenyon Ave, Suite 103, Wakefield, RI 02879 Phone: 401-789-0661 Fax: 401-788-3958 |